Current use of fluoroquinolones associated with higher risk of developing retinal detachment - GreenMedInfo Summary
Oral fluoroquinolones and the risk of retinal detachment.
JAMA. 2012 Apr 4 ;307(13):1414-9. PMID: 22474205
Therapeutic Evaluation Unit, Child and Family Research Institute of British Columbia, Vancouver, Canada. [email protected]
CONTEXT: Fluoroquinolones are commonly prescribed classes of antibiotics. Despite numerous case reports of ocular toxicity, a pharmacoepidemiological study of their ocular safety, particularly retinal detachment, has not been performed.
OBJECTIVE: To examine the association between use of oral fluoroquinolones and the risk of developing a retinal detachment.
DESIGN, SETTING, AND PATIENTS: Nested case-control study of a cohort of patients in British Columbia, Canada, who had visited an ophthalmologist between January 2000 and December 2007. Retinal detachment cases were defined as a procedure code for retinal repair surgery within 14 days of a physician service code. Ten controls were selected for each case using risk-set sampling, matching on age and the month and year of cohort entry.
MAIN OUTCOME MEASURE: The association between retinal detachment and current, recent, or past use of an oral fluoroquinolone.
RESULTS: From a cohort of 989,591 patients, 4384 cases of retinal detachment and 43,840 controls were identified. Current use of fluoroquinolones was associated with a higher risk of developing a retinal detachment (3.3% of cases vs 0.6% of controls; adjusted rate ratio [ARR], 4.50 [95% CI, 3.56-5.70]). Neither recent use (0.3% of cases vs 0.2% of controls; ARR, 0.92 [95% CI, 0.45-1.87]) nor past use (6.6% of cases vs 6.1% of controls; ARR, 1.03 [95% CI, 0.89-1.19]) was associated with a retinal detachment. The absolute increase in the risk of a retinal detachment was 4 per 10,000 person-years (number needed to harm = 2500 computed for any use of fluoroquinolones). There was no evidence of an association between development of a retinal detachment andβ-lactam antibiotics (ARR, 0.74 [95% CI, 0.35-1.57]) or short-acting β-agonists (ARR, 0.95 [95% CI, 0.68-1.33]).
CONCLUSION: Patients taking oral fluoroquinolones were at a higher risk of developing a retinal detachment compared with nonusers, although the absolute risk for this condition was small.
